Divalproex Sodium Tablet, Delayed Release
Product Images NDC 68001-473

11 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68001-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 01)

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 01)
Chemical structure of Divalproex Sodium, showing its molecular formula with sodium ion, carbon, hydrogen, and oxygen atoms arranged to represent the compound's chemical composition.*
FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 02)

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 02)
A bar chart comparing percentages for two studies (Study 1 and Study 2) with labels PBO and DVPX on the x-axis and percentage on the y-axis. In Study 1, PBO shows 26% and DVPX shows 60%. In Study 2, PBO shows 29% and DVPX shows 58%.*
FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 03)

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 03)
A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium and placebo across the percentage of patients. The y-axis shows percent reduction in CPS rate from -100% (worsening) to 100% (improvement), and the x-axis shows percent of patients from 100 to 0. Two lines are compared: a solid line for Divalproex Sodium and a dashed line for placebo, illustrating treatment effect differences.*
FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 04)

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 04)
A line graph comparing the percentage reduction in CPS Rate between high and low doses of Divalproex Sodium tablets. The x-axis represents the percentage of patients, while the y-axis shows percentage change in CPS Rate, with improvement indicated above and worsening below the zero line.*
FDA Label Image

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 05)

Image (8928887a 8c8b 4a61 8bc9 A3026d60db17 05)
A bar chart comparing the effects of Placebo and Divalproex Sodium in two separate studies labeled Study 1 and Study 2. The vertical axis is labeled with numerical values. The chart visually contrasts data outcomes between the placebo and Divalproex Sodium groups in each study.*
FDA Label Image

Dival 500mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 500mg 100ct)

Dival 500mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 500mg 100ct)
Label for Divalproex Sodium Delayed Release Tablets, USP 500 mg oral tablets, manufactured by Unichem Laboratories Ltd. and labeled by BluePoint Laboratories. The package contains 100 tablets with valproic acid activity. The label includes storage instructions at 20° to 25°C and cautions for dispensing in a tight, light-resistant container. The NDC 68001-474-00 is shown along with a barcode.*
FDA Label Image

Dival 250mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 250mg 100ct)

Dival 250mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 250mg 100ct)
Label for Divalproex Sodium Delayed Release Tablets, USP 250 mg by BluePoint Laboratories. The label specifies the tablet strength as 250 mg, mentions valproic acid activity, and includes storage instructions. It also notes the product is prescription only and is packaged with 100 tablets. Manufacturer details for Unichem Laboratories Ltd. in India are included.*
FDA Label Image

Dival 125mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 125mg 100ct)

Dival 125mg 100ct Rev 07/2025 (Divalproex Sodium Dr Tablets Usp 125mg 100ct)
Label for Divalproex Sodium Delayed Release Tablets, USP 125 mg, oral tablets in a bottle pack of 100. The label displays the dosage strength prominently in the center with mention of valproic acid activity. It indicates a prescription-only status (Rx Only) and storage instructions at controlled room temperature. Manufactured by Unichem Laboratories Ltd. for BluePoint Laboratories.*
FDA Label Image

Divalproex Dr 125mg (Divalproex Dr Tablets 125mg 100s Label Rev 09 2023)

Divalproex Dr 125mg (Divalproex Dr Tablets 125mg 100s Label Rev 09 2023)
Label for Divalproex Sodium Delayed Release Tablets USP, 125 mg strength, displaying Valproic Acid activity. The label includes storage instructions, pharmacist dispensing guidance, and manufacturer information (Unichem Laboratories Ltd.) with BluePoint Laboratories as labeler. The package contains 100 tablets with NDC 68001-472-00 and a barcode.*
FDA Label Image

Divalproex Dr Tabs 250mg (Divalproex Dr Tablets 250mg 100s Label Rev 09 2023)

Divalproex Dr Tabs 250mg (Divalproex Dr Tablets 250mg 100s Label Rev 09 2023)
Label for Divalproex Sodium Delayed Release Tablets, USP 250 mg by BluePoint Laboratories. The label states the product contains valproic acid equivalent to 250 mg and is packaged as 100 tablets. It includes storage instructions (20° to 25°C) and is manufactured by Unichem Laboratories Ltd., India. The NDC is 68001-473-00.*
FDA Label Image

Divalproex Dr Tabs 500mg (Divalproex Dr Tablets 500mg 100s Label Rev 09 2023)

Divalproex Dr Tabs 500mg (Divalproex Dr Tablets 500mg 100s Label Rev 09 2023)
Label for Divalproex Sodium Delayed Release Tablets, USP, 500 mg strength. The label includes storage instructions, dispensing guidelines, and a NDC number 68001-474-00. It states the product contains Divalproex Sodium equivalent to 500 mg Valproic acid per delayed-release tablet. The package contains 100 tablets and is manufactured by Unichem Laboratories Ltd. for BluePoint Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.